HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ONO-6818 Cortech/Ono.

Abstract
ONO-6818 (CP-955) is the lead compound in a series of orally bioavailable neutrophil elastase inhibitors licensed from Cortech and under investigation by Ono for the potential treatment of inflammatory conditions, such as rheumatoid arthritis, inflammatory bowel disease and chronic obstructive pulmonary disease (COPD) [174095]. ONO-6818 was in phase I studies for COPD in Japan as of December 1999 [366431]. Phase I trials for this indication in Japan and the US were ongoing in September 2001 [368565], [422782], [446138]. As of June 2002, however, a number of unconfirmed reports stated that the compound had moved into phase II trials in Japan and was in preparation for phase II trials in the US [456596], [456597].
AuthorsAlexandre Trifilieff
JournalCurrent opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 3 Issue 8 Pg. 1161-4 (Aug 2002) ISSN: 1472-4472 [Print] England
PMID12211408 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents
  • Enzyme Inhibitors
  • ONO 6818
  • Oxadiazoles
  • Pyrimidinones
  • Leukocyte Elastase
Topics
  • Animals
  • Anti-Inflammatory Agents (chemical synthesis, metabolism, pharmacology, therapeutic use)
  • Clinical Trials, Phase I as Topic
  • Enzyme Inhibitors (chemical synthesis, metabolism, pharmacology, therapeutic use)
  • Humans
  • Leukocyte Elastase (antagonists & inhibitors)
  • Oxadiazoles (chemical synthesis, metabolism, pharmacology, therapeutic use)
  • Pyrimidinones (chemical synthesis, metabolism, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: